Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.639
-0.034 (-4.98%)
At close: Mar 9, 2026, 4:00 PM EDT
0.610
-0.029 (-4.52%)
After-hours: Mar 9, 2026, 5:22 PM EDT
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $66.00 million as of March 9, 2026. Its market cap has increased by 186.84% in one year.
Market Cap
66.00M
Enterprise Value
93.22M
1-Year Change
186.84%
Ranking
Category
Stock Price
$0.64
Market Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $66.00M, an increase of 91.33%. That is a compound annual growth rate of 55.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 70.35M | 33.15% |
| Dec 31, 2025 | 52.83M | 216.73% |
| Dec 31, 2024 | 16.68M | -51.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coeptis Therapeutics Holdings | 74.92M |
| Pelthos Therapeutics | 74.81M |
| Adicet Bio | 73.67M |
| Fractyl Health | 73.62M |
| XBiotech | 71.65M |
| Cingulate | 66.99M |
| MediciNova | 66.94M |
| Actuate Therapeutics | 66.48M |